meliorpharmaceuticals.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Melior Pharmaceuticals | Biopharmaceutical Research & Development Company |
| Description | Developing Innovative Therapies to Change Melior Pharmaceuticals is a mid-stage biopharmaceuticals company in Pennsylvania that develops therapies for diabetes and parkinson’s |
| Keywords | biopharmaceutical company, biopharmaceutical research company, biopharmaceutical development company, melior pharmaceuticals Pennsylvania |
Server Information
| WebSite | |
| Host IP | 206.188.193.17 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
meliorpharmaceuticals.com Valuation
|
US$1,661,497
Last updated: 2023-05-08 14:16:06
meliorpharmaceuticals.com has Semrush global rank of 6,370,342. meliorpharmaceuticals.com has an estimated worth of US$ 1,661,497, based on its estimated Ads revenue. meliorpharmaceuticals.com receives approximately 191,712 unique visitors each day. Its web server is located in United States, with IP address 206.188.193.17. According to SiteAdvisor, meliorpharmaceuticals.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,661,497 |
| Daily Ads Revenue | US$1,534 |
| Monthly Ads Revenue | US$46,011 |
| Yearly Ads Revenue | US$552,129 |
| Daily Unique Visitors | 12,781 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| meliorpharmaceuticals.com. 7200 | A | meliorpharmaceuticals.com. 7200 | IP: 206.188.193.17 |
| meliorpharmaceuticals.com. 7200 | NS | meliorpharmaceuticals.com. 7200 | NS Record: ns85.worldnic.com. |
| meliorpharmaceuticals.com. 7200 | NS | meliorpharmaceuticals.com. 7200 | NS Record: ns86.worldnic.com. |
HtmlToTextCheckTime:2023-05-08 14:16:06
| Management Team News & Publication Contact Us MENU About Us Our Pipeline Our Science Tolimidone Mesocarb Melior Discovery Partners & Investors Management Team News & Publications Contact Us i thought about this find out buy gabapentin online Domperidonum Developing Innovative Therapies to Change Lives Melior Pharmaceuticals is a mid-stage biopharmaceutical company developing a pipeline of innovative, de-risked drug candidates in disease areas with significant unmet needs. Melior leverages its proprietary drug screening technology to identify new and patentable uses for drugs that have been developed for other indications and that have significant clinical safety history. Our leading drug candidates are in early to mid-stage clinical development for Type 2 Diabetes, Nonalcoholic Steatohepatitis (NASH), Parkinson’s Disease and Sleep Disorders. LEARN MORE Expanding the Pipeline Melior’s pipeline includes, (1) Tolimidone, a novel lyn kinase activator, currently in development for Type 2 |
HTTP Headers
HTTP/1.1 200 OK Server: openresty/1.17.8.2 Date: Sat, 30 Oct 2021 04:31:15 GMT Content-Type: text/html Content-Length: 10211 Connection: keep-alive Vary: Accept-Encoding Last-Modified: Tue, 16 Oct 2018 14:19:32 GMT ETag: "27e3-578593e0cc500" X-Webcom-Cache-Status: BYPASS Accept-Ranges: bytes |
meliorpharmaceuticals.com Whois Information
Domain Name: MELIORPHARMACEUTICALS.COM Registry Domain ID: 1352940265_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.networksolutions.com Registrar URL: http://networksolutions.com Updated Date: 2018-09-11T14:35:33Z Creation Date: 2007-12-11T19:22:04Z Registry Expiry Date: 2021-12-11T19:22:04Z Registrar: Network Solutions, LLC Registrar IANA ID: 2 Registrar Abuse Contact Email: abuse@web.com Registrar Abuse Contact Phone: +1.8003337680 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS85.WORLDNIC.COM Name Server: NS86.WORLDNIC.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-17T15:30:35Z <<< |